Literature DB >> 22276281

Rheumatic fever - identification, management and secondary prevention.

Michael T Smith1, Yvonne Zurynski, David Lester-Smith, Elizabeth Elliott, Jonathan Carapetis.   

Abstract

BACKGROUND: Acute rheumatic fever is a rare multisystem disease caused by an immunological response to Group A streptococcus infection. Acute rheumatic fever usually has onset in childhood and is most prevalent in Aboriginal and Maori populations and other disadvantaged groups.
OBJECTIVE: In this article we outline the clinical features of acute rheumatic fever and describe the important role of primary healthcare providers in its identification, management and secondary prevention. DISCUSSION: Recurrent episodes of acute rheumatic fever may lead to rheumatic heart disease. Early detection of acute rheumatic fever and provision of secondary prophylaxis with antibiotics is paramount to the prevention of rheumatic heart disease. Primary healthcare providers can play an important role in identifying acute rheumatic fever and ensuring adherence to treatment within the context of a complex interplay of cultural and socioeconomic factors. The recent establishment of RHD Australia will support the development of appropriate educational resources and their dissemination among health professionals and vulnerable communities.

Entities:  

Mesh:

Year:  2012        PMID: 22276281

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  4 in total

1.  Streptococcal-vimentin cross-reactive antibodies induce microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease.

Authors:  F Delunardo; V Scalzi; A Capozzi; S Camerini; R Misasi; M Pierdominici; M Pendolino; M Crescenzi; M Sorice; G Valesini; E Ortona; C Alessandri
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

2.  Prevalence of group a Beta-hemolytic streptococcus oropharyngeal colonization in children and therapeutic regimen based on antistreptolysin levels: data from a city from southern Brazil.

Authors:  Alexandre B Merlini; Carolina S Stocco; Marcelo D Schafranski; Polliane Arruda; Larissa Bail; Celso L Borges; Cecília F Dornelles
Journal:  Open Rheumatol J       Date:  2014-07-11

3.  Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network.

Authors:  Jillian S Y Lau; Christopher Kiss; Erika Roberts; Kylie Horne; Tony M Korman; Ian Woolley
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-01-18       Impact factor: 3.944

4.  Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study.

Authors:  Hilary Barker; John G Oetzel; Nina Scott; Michelle Morley; Polly E Atatoa Carr; Keri Bolton Oetzel
Journal:  Int J Equity Health       Date:  2017-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.